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ABSTRACT
Objective: A reliable and easy-to-perform method for measuring right ventricular (RV) afterload is desirable when scheduling patients with 
systolic heart failure to undergo heart transplantation. The present study aimed to investigate the accuracy of echocardiographically-derived 
pulmonary arterial elastance as a measurement of pulmonary vascular resistance by comparing it with invasive measures.
Methods: Thirty-one patients with moderate to severe systolic heart failure, including 22 (71%) male patients, with a mean age of 41.16±15.9 
years were enrolled in the study. Right heart catheterization and comprehensive echocardiography during the first hour after completion of 
cardiac catheterization were performed in all the patients. The pulmonary artery elastance was estimated using the ratio of end-systolic pres-
sure (Pes) over the stroke volume (SV) by both cardiac catheterization [Ea (PV)-C] and echocardiography [Ea (PV)-E].
Results: The mean Ea (PV)-C and Ea (PV)-E were estimated to be 0.73±0.49 mm Hg/mL and 0.67±0.44 mm Hg/mL, respectively. There was a 
significant relation between Ea (PV)-E and Ea (PV)-C (r=0.897, p<0.001). Agreement between echocardiography and catheterization methods for 
estimating Ea (PV), investigated by the Bland-Altman method, showed a mean bias of -0.06, with 95% limits of agreement from -0.36 mm Hg/mL 
to 0.48 mm Hg/mL.
Conclusion: Doppler echocardiography is an easy, non-invasive, and inexpensive method for measuring pulmonary arterial elastance, which 
provides accurate and reliable estimation of RV afterload in patients with systolic heart failure. (Anatol J Cardiol 2016; 16: 183-8)
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Introduction
Because of the current evidence regarding the increasing 
number of hospitalizations for pulmonary arterial elastance and 
death rate secondary to the heart failure and also the cost 
expended annually for taking care of these patients, this issue is 
transforming into a global epidemic (1). The function of the right 
ventricle in congestive heart failure is one of the strong outcome 
predictors (2, 3), and the most prevalent cause of the right heart 
failure is indeed the left ventricular failure. In these conditions, the 
increase of right ventricular (RV) afterload will lead to a decrease 
of right ventricular ejection fraction (RVEF), stroke volume, and 
cardiac output and eventually lead to progressive RV failure (4-6). 
Thus, RV afterload evaluation in patients suffering from systolic 
heart failure will help to predict the RV function in future. 
Moreover, in advanced heart failure patients who are candidates 
for heart transplantation, the RV afterload has an essential role in 
making a decision regarding placing them on the transplant list 
and to predict the prognosis after transplantation (7). At the pres-
ent time, the standard method for examining the RV afterload in 
these patients is measuring pulmonary vascular resistance by 
right-sided catheterization, which is the average of pressure drop 
in the pulmonary arterial tree over the average of pulmonary flow. 
This method is based on the assumption of steady hemodynam-
ics, suggesting that it is a fixed and stable hemodynamic (8). 
However, because RV afterload and pulmonary artery hemody-
namics are induced through the acute and chronic changes cre-
ated in compliance and pressure waves return in proximal pulmo-
nary artery, it is important and vital to use other methods which 
seem to be more useful in a thorough and complete estimation of 
RV afterload (9, 10). The examination of pulmonary artery imped-
ance is a much more precise method in the estimation of pulmo-
nary arterial hypertension (11); on the other hand, it is very difficult 
to use it for the treatment of patients, considering the complexity 
of this method. Effective arterial elastance (Ea), which includes 
the systolic pressure gradient curve over the stroke volume (SV), 
is one of the indices used to overcome the abovementioned prob-
lems in the afterload estimation (12-15).
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All of the above indices are calculated invasively through 
right heart catheterization. However, the use of other non-inva-
sive methods such as echocardiography and magnetic reso-
nance imaging (MRI) to calculate the hemodynamic indices has 
always been considered, particularly, Doppler echocardiogra-
phy, which is able to determine the cardiac hemodynamics in a 
non-invasive manner, has significantly impacted clinical medi-
cine. Because it is possible to find the pressure and flow vari-
ables through the Doppler, we have assumed that we may be 
able to precisely estimate the pulmonary arterial elastance 
through the Doppler obtained variables in the present study.
Methods
In this study, 31 patients with moderate to severe systolic 
heart failure (left ventricular ejection fraction <35%) have been 
examined. All of the patients were referred to the heart failure 
clinic of Rajaei Cardiovascular, Medical and Research Center, 
Tehran, Iran (a tertiary health care center for cardiovascular 
disease) between May 2009 and January 2010 to undergo right 
heart catheterization.
Right heart catheterization was performed for all of the 
patients, and comprehensive echocardiography was performed 
during the first hour after completion of cardiac catheterization. 
The patients with a shunt in the heart and atrial fibrillation with 
rapid ventricular response were excluded from the study.
 The present study was conducted in accordance with the 
ethical guidelines of the Declaration of Helsinki. Institutional 
Review Boards at Iran University of Medical Science approved 
the study protocol, and written informed consent was obtained 
from all patients.
Right heart catheterization
Standard right heart catheterization was performed using 
Edwards Life Sciences Swan Ganz catheters (Irvine, CA) via the 
right jugular vein. The right side pressures, including pulmonary 
arterial and pulmonary capillary wedge pressures, for estimat-
ing the left atrium pressure were obtained using the fluid-filled 
system. All of the pressures were obtained at the end of the 
expiration, and the zero point in the mid-chest level and also the 
average of 10 wave burst was considered for the calculation. 
Measuring cardiac output
The cardiac output was measured with both the thermodilu-
tion technique and direct Fick method.
Thermodilution technique 
A 10 mL sterile, ice-cold isotonic (0.9%) saline was inject-
ed through the proximal (right atrial) lumen of the catheter 
and its temperature was measured by a thermistor that was 
placed directly behind the right atrial inlet of the catheter. The 
drop in temperature at the distal thermistor was subsequently 
recorded.
Cardiac output was calculated using an analog computer 
system (REF-1, ejection fraction cardiac output computer; 
Baxter Healthcare Corp. Santa Ana, CA).
Direct Fick method
PO2, PCO2, pH, base excess, and (calculated) SaO2 were 
determined from arterial and mixed venous blood samples, 
which were simultaneously obtained via the arterial line and 
the distal (pulmonary arterial) opening of the Swan-Ganz cath-
eter, respectively (ABL 520; Radiometer, Copenhagen, Denmark). 
The arterial and mixed venous oxygen contents (CaO2 and 
CvO2) were calculated as the product of hemoglobin (g/L), the 
hemoglobin-binding constant for oxygen (1.34 g/L), and oxygen 
saturation.
Oxygen content of blood=[hemoglobin] (g/dL)×1.34 (mL O2/g 
of hemoglobin)×saturation of blood (percent)
Oxygen consumption (VO2) was measured while the blood 
samples were obtained using a commercially available sys-
tem (Oxycon Champion 3.0; Jaeger, Würzburg, Germany).
The cardiac output was subsequently calculated according 
to the formula:
Q = VO2/(CaO2-CvO2).
Pulmonary arterial elastance measured by catheterization 
[Ea (PV)-C]
The catheterization-derived effective arterial elastance of 
the pulmonary artery [Ea (PV)-C] was calculated using the fol-
lowing formula (14):
Ea (PV)-C=Pes/SV,
where Pes is the pulmonary artery systolic pressure (the 
pressure is considered as the arterial end-systolic pressure at 
the dicrotic notch) and SV is the stroke volume.
Doppler echocardiography
The Doppler echocardiography was performed using the GE 
Vivid 3 ultrasound. By locating a 1-2 mm pulsed wave sample 
volume in parasternal short axis, the velocity-time integral of 
right ventricular outflow tract flow (RVOT VTI) was obtained in 
the proximity of the RVOT, just within the pulmonary valve. The 
sample volume was located as the sound of the closing and not 
the opening click of the valve would be clear. The continuous 
wave Doppler was used to determine the tricuspid regurgitation 
(TR) velocity in peak and also the end of systole (at the peak of 
the T wave in electrocardiogram). The TR waves were chosen 
from the specific fields where it had the best velocity and the 
best signal, and the agitated saline was used when there was a 
sub-optimal signal in some cases (16).
Generally, we have used the average of five signals for the 
calculation and the average of 10 signals for the patients with 
atrial fibrillation. The echocardiographic physician was blind to 
the result of the patients’ catheterization.
SV was obtained using the following formula (17):
SV=D2×0.785×VTI,
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where SV is the Stroke Volume, D is the RVOT diameter and 
VTI is velocity-time integral of the RVOT. The RVOT diameter was 
calculated in the parasternal short axis, right before the pulmo-
nary valve and the average of three times was used.
The pulmonary artery systolic pressure (Pes)
Pes was obtained by this formula:
Pes=4×(ESTRV)2+RAP,
where ESTRV stands for velocity wave of TR in end-systole 
(velocity wave in the peak of the T wave in the simultaneous 
electrocardiogram) (Fig. 1), and RAP is the right arterial pres-
sure, which was estimated using the inferior vena cava diameter 
and its collapsibility during breathing (18).
Pulmonary arterial elastance estimated by echocardiography 
[Ea (PV)-E]
All echocardiographic measurements were performed using a 
commercially available ultrasound system (Vivid 7, GE Medical 
Systems, Inc., Horten, Norway). Pulmonary arterial elastance [Ea 
(PV)-E] was estimated using the ratio of end-systolic pressure 
over the stroke volume obtained from the echocardiography.
Statistical analysis
Data were described as mean±standard deviation (SD) for 
interval and count (percentage) for categorical variables. Fitness 
of interval variables to Gaussian distribution was examined by 
one-sample Kolmogorov-Smirnov test. Linear correlations 
between the indices were estimated by Pearson’s r (for nor-
mally distributed data) and Spearman’s rho (for non-normally 
distributed data) correlation coefficients. The level of agreement 
between the two measurement methods {effective pulmonary 
elastance measured by catheterization [Ea (PV)-C] and calcu-
lated pulmonary elastance estimated by echocardiography [Ea 
(PV)-E]} was assessed using the Bland-Altman method. A p 
value <.05 was considered statistically significant. Statistical 
analysis was performed by SPSS 15 for Windows (SPSS Inc, 
Chicago, IL, USA).
Results
Thirty-one out of 42 patients were included in this study; 11 
of them did not have an appropriate TR flow and were excluded 
from the study. The majority of patients were males (22 patients, 
71%). The mean age was 41.16±15.90 years, and the mean body 
surface area was 1.71±0.19 m2. The most common etiology was 
non-ischemic dilated cardiomyopathy (19 patients, 61%), and the 
second most common etiology was ischemic cardiomyopathy (9 
patients, 26%). The basic clinical features of patients are sum-
marized in Table 1.
Figure 1. a, b. Diagram showing the tricuspid regurgitation flow across the tricuspid valve and the simultaneous echocardiography (ECG) 
recording (a); Continuous-wave Doppler ECG tracing at the level of tricuspid valve in a study patient (with systolic heart failure) (b). End-systolic 
tricuspid regurgitation velocity (ESTRV) is considered as the peak of the T wave in the simultaneous ECG (arrow head)
VTI - velocity time integral
a b
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Pulmonary hemodynamic variables
Pulmonary hemodynamic variable features of the study 
patients are summarized in Table 2.
A strong and significant correlation was observed between 
Ea (PV)-E and Ea (PV)-C (r=0.897 and p<0.001).
Moreover, for assessing the agreement between Ea (PV)-C 
and Ea (PV)-E, we applied the Bland-Altman method to obtain 
the agreement plot (Fig. 2). The mean difference (bias) of the 
measurements between echocardiography and catheterization 
methods is -0.06 (p=0.10). The SD of the difference is 0.21 and the 
95% limits of agreement (mean±1.96 SD) range from -0.36 mm 
Hg/mL to 0.48 mm Hg/mL. To ensure the absence of a propor-
tional error, a linear regression analysis was performed between 
the difference and mean of the two measurements (Table 3).
Discussion
In the present study, we used echocardiography to assess 
the pulmonary arterial elastance as a factor of RV afterload. 
There was a significant increase of the pulmonary vascular 
resistance in congestive heart failure (CHF); however, this factor 
shows us a stable flow and does not explain the pulsatile flow 
completely, which is seen in a vascular bed with low pressure 
and high compliance (19). On the other hand, because of the low 
resistance and high compliance in the pulmonary blood flow, the 
pulsatile hydraulic load components are highly important and it 
has to be considered (20). Several studies have shown that the 
pulsatile load increases in chronic pulmonary hypertension, 
which can be determined by the rise in impedance characteris-
tics and wave reflection. This type of unusual pulsatile load may 
have unsuitable effects on the ventricular-vascular coupling 
because of the increase in pulsatile ventricular power and con-
sequently inappropriate loading on the ejecting RV (9, 21, 22). As 
it was mentioned before, pulmonary arterial impedance evalua-
tion is a much more precise and complete method for estimating 
the pulmonary arterial load (11); however, because of the com-
plexity of this method, it is totally difficult to use it for the 
Gender, M/F 22 (71)/9 (29)
Age, years 41.16±15.90
Height, cm 163.20±31.23
Weight, kg 66.13±12.91
BSA, m2 1.71±0.19
Diagnosis
DCM 19 (61)
ICMP 8 (26)
HCM 1 (3)
VHD 2 (7)
PPCMP (3)
Data are presented as numbers (percentage) and mean±standard deviation. 
BSA - body surface area; DCM - dilated cardiomyopathy; HCM - hypertrophic 
cardiomyopathy; ICMP - ischemic cardiomyopathy; PPCMP - postpartum 
cardiomyopathy; VHD - valvular heart disease (other than aortic stenosis)
Table 1. Baseline characteristics of patients
Hemodynamic data Mean±SD
Right atrial pressure, mm Hg 9.83±6.24
PA pressure (systolic/diastolic), mm Hg 45.83/23.60±28.54/14.11
Mean PA pressure, mm Hg 31.43±18.47
Pulmonary capillary wedge pressure, mm Hg 18.91±10.44
Pulmonary vascular resistance, dyn.s/cm5 181.46±128.79
Cardiac output, L/min
Fick 4.50±1.22
Thermodilution 4.31±0.95
Cardiac index Thermodilution, L/min/m2 2.52±0.54
Stroke volume, mL 56.31±18.73
Ea (PV)-C, mm Hg/mL† 0.73±0.49
Ea (PV)-E, mm Hg/mL‡ 0.67±0.44
Ea (PV) - arterial elastance of pulmonary vasculature; PA - pulmonary artery. 
†Ea (PV) - with catheterization; ‡Ea (PV) - with echocardiography
Table 2. Pulmonary hemodynamic variables
Figure 2. Bland-Altman plot. The difference between echocardiography 
and catheterization-derived pulmonary arterial elastance is drawn 
against the mean of the two measurements
Mean ([Ea(PV).C + Ea(PV).E]/2)
0.00 0.50 1.00 1.50 2.00
0.50
0.25
0.00
-0.25
-0.50
Mean -1.96SD=-0.36
Mean +1.96SD=-0.48
Mean difference (-0.06 mm Hg/mL)
95% limits of agreement
Mean=-0.06
Constant Coefficient±SE P
Mean of two 0.054±.074 0.699
measurement methods† 1.018±0.093 0.132
Abbreviation: Ea (PV), arterial elastance of pulmonary vasculature. 
†[Ea (PV)-C+Ea (PV)-E]/2
Table 3. Linear regression between mean and difference of two 
measurement methods of Ea (PV) (Dependent variable: Difference of 
two measurement methods)
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patients. Sunagawa et al. (12) has thought up the concept of 
effective arterial elastance, which is a parameter including the 
basic elements of the Windkessel model in the vascular bed 
(12, 23). Sunagawa et al. (23) have demonstrated that Ea (PV) is 
a useful factor in the evaluation of arterial load and its interfer-
ence with ventricular function. These researchers have also 
suggested that this factor is considered as a strong and long-
lasting index in the evaluation of pulsatile load repercussions 
with an increase in age and hypertension. These studies have 
shown that the average intensity in arteries often underesti-
mates the real load effect on the heart function (13). Morimont 
et al. (14) have also studied this factor for pulmonary arteries in 
different loading conditions. One alternative for the calculation 
of Ea is using the ratio of Pes over SV. Many scientists have used 
artery pressure in the dicrotic notch to estimate Pes and some 
have used peak pressure (24-28). However, in this study, we have 
used Pes in the dicrotic notch.
Assessment of RV afterload in systolic heart failure patients 
seems necessary because it provides both therapeutic and 
prognostic implications. Previous studies have demonstrated 
that pulmonary hypertension and resultant right heart dysfunc-
tion is increasingly common in patients with systolic heart fail-
ure, which potently affects exercise capacity and clinical out-
come in these patients, regardless of left ventricular ejection 
fraction (29, 30). In patients with advanced heart failure, the 
presence of pulmonary vascular resistance and its reactivity to 
vasodilators such as nitric oxide donators, milrinone, the phos-
phodiesterase-5 inhibitor sildenafil, and the natriuretic peptide 
nesiritide are in extensive use to define the patients` eligibility 
for cardiac transplantation. [Ea (PV)] is a measure of total RV 
afterload, which reflects both the resistive and pulsatile compo-
nents. In left heart failure patients with pulmonary hypertension, 
Ea (PV) has also been found to be able to discriminate survivors 
from non-survivors over a mean time period of 4.4 years (31). 
Currently, right heart catheterization is considered the gold 
standard method for the assessment of the pulmonary vascula-
ture hemodynamics. However, as an invasive and expensive 
procedure, it has its known specific limitations and complica-
tions. Nowadays, echocardiography is highly considered as an 
easy and non-invasive method in patients for diagnostic and 
prognostic evaluation. Doppler echocardiography is quietly pre-
cise for the estimation of simple cardiac hemodynamic mea-
sures, and the TR flow is used to estimate the RV systolic pres-
sure and pulmonary artery pressures (32). In addition, we can 
estimate the RV SV using the RVOT VTI and RVOT diameter using 
echocardiography (17). Thus, in this study, we have suggested 
that it is possible to estimate the pulmonary artery elastance 
through the use of TR flow gradient at the end of systole and the 
RV SV, which is obtained by the hydraulic orifice formula. As it 
was mentioned, there is a strong and significant relation 
between the calculated elastance by echocardiography and the 
one obtained from right heart catheterization. With the increas-
ing importance of non-invasive methods in the evaluation of 
patients suffering from heart failure and also because of the 
absolute need to identify some necessary factors for estimating 
the RV afterload more precisely, the use of this factor in addition 
to the pulmonary arterial resistance may further help us to 
evaluate the patients with heart failure.
Study limitations
In the present study, we used the fluid-filled catheters to cal-
culate the pressure. Although it is quite obvious that using a high-
fidelity pressure transducer catheter is more precise for studying 
the hemodynamics, these catheters are expensive and complex 
and it is difficult to use them in clinical settings. However, we have 
also used the dicrotic notch to estimate Pes, while the final time 
of blood drainage depends on both the external loading and myo-
cardial contractility. It is necessary to have a full profile tricuspid 
insufficiency Doppler curve through the systole, including end-
systole, to estimate the pulmonary arterial pressure and Pes.
Conclusion
Considering the important effectiveness of RV afterload on 
RV ejection fraction and pulmonary artery elastance as a sur-
rogate of RV afterload, it seems completely essential to deter-
mine Ea (PV) in patients with systolic heart failure for both 
therapeutic and prognostic decision making. Doppler echocar-
diography is an easy, non-invasive, and inexpensive way for 
measuring pulmonary arterial elastance, which provides accu-
rate and reliable estimation of RV afterload in patients with 
systolic heart failure.
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